BRIEF

on Catheter Precision, Inc

Catheter Precision, Inc. Expands LockeT Distribution to Middle East

FORT MILL, SC – Catheter Precision, Inc. (NYSE American: VTAK), a US-based innovator in medical devices for electrophysiology, has established a distribution agreement for its LockeT device with Dubai-based Forum Medical. The agreement further extends LockeT’s reach into Georgia, Uzbekistan, and Kazakhstan.

David Jenkins, CEO of Catheter Precision, emphasized the device's benefits: “LockeT is a low-cost device that ensures quick hemostasis after venous access, reducing staff and time burdens.” Jenkins highlighted its increasing global demand, including in the U.S.

LockeT is a suture retention device that aids hemostasis post-venous puncture and holds Class 1 FDA registration. This expansion is expected to provide significant support to physicians in these new markets, enhancing patient care.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Catheter Precision, Inc news